Medartis Holding AG

MED · SW · Healthcare / Medical Devices

109.00CHF+0.20 (+0.18%)

Price History

Full chart

Market Stats

Previous Close108.80

Open108.60

Day Range108.40 – 110.00

52-Week Range70.60 – 97.50

Volume10.23K

Market Cap1.02B

P/E (TTM)68.42

Forward P/E123.46

EPS1.20

Dividend Yield0.00%

Beta1.17

50-Day Avg87.13

200-Day Avg84.36

About

Medartis Holding AG, a medical device company, engages in the development, manufacturing, and sales of implant solutions worldwide. The company's medical devices are used for the treatment of surgical fixation of bone fractures for upper and lower extremities, as well as for the cranio-maxillofacial surgery. It provides products for the hand, wrist, forearm, elbow, shoulder, and foot and ankle, as well as for upper and lower extremities, mandible, midface, orthognathic under the APTUS and MODUS names, as well as CMX services through web portal, and kerimedical products. The company was incorporated in 1997 and is headquartered in Basel, Switzerland.

Company Details

SectorHealthcare
IndustryMedical Devices
CEOMr. Matthias Schupp
Employees1.43K
HeadquartersHochbergerstrasse 60E, Basel, Switzerland, 4057, Switzerland
Websitehttps://www.medartis.com

Leadership

Mr. Matthias SchuppCEO & Member of the Executive Management Board · b. 1964
Dr. Thomas StraumannFounder & Vice Chairman · b. 1963
Dr. Peter Hackel Ph.D.CFO & Member of Executive Management Board · b. 1969
Ms. Mareike LochPresident of EMEA & Member of Executive Management Board · b. 1970
Mr. Mario Della CasaCOO & Member of Management Board · b. 1975
Mr. David ThoniPresident of US & Member of Executive Management Board · b. 1965
Ms. Caroline KnoeriChief Human Resources Officer & Executive Management Board Member · b. 1975
Mr. Marc AmmannExecutive Vice President of R&D and Innovation and Member of the Executive Management Board · b. 1978
Ms. Anisha WhartonHead of Regulatory Affairs

Financials

Income Statement

Currency: CHF	2015-12-31	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Total Revenue	82.30M	92.50M	105.04M	121.32M	130.14M	127.65M	159.88M	182.82M	212.01M	224.83M	269.26M
Growth (%)	-	+12.39%	+13.55%	+15.50%	+7.27%	-1.92%	+25.25%	+14.35%	+15.96%	+6.05%	+19.76%
Cost of Revenue	14.15M	16.50M	17.48M	20.31M	28.84M	33.76M	38.31M	47.44M	44.43M	46.15M	64.93M
Gross Profit	68.15M	76.00M	87.57M	101.01M	101.30M	93.89M	121.57M	135.39M	167.57M	178.68M	204.33M
Gross Margin	82.80%	82.16%	83.36%	83.26%	77.84%	73.55%	76.04%	74.05%	79.04%	79.47%	75.89%
Operating Expense	56.00M	68.77M	77.96M	94.95M	93.95M	90.76M	110.56M	137.31M	158.47M	170.82M	202.40M
Operating Income	12.15M	7.23M	9.61M	6.06M	7.35M	3.13M	11.01M	-1.92M	9.10M	7.87M	1.93M
Operating Margin	14.76%	7.82%	9.15%	4.99%	5.65%	2.45%	6.89%	-1.05%	4.29%	3.50%	0.72%
EBITDA	15.11M	12.99M	16.95M	11.25M	20.34M	13.96M	26.10M	15.64M	24.69M	30.18M	45.72M
EBITDA Margin	18.36%	14.05%	16.13%	9.28%	15.63%	10.94%	16.33%	8.56%	11.65%	13.43%	16.98%
Net Income	7.27M	3.31M	866.52K	4.20M	2.15M	-943.57K	6.84M	-5.78M	619.00K	3.53M	8.35M
Net Income Margin	8.83%	3.58%	0.82%	3.46%	1.65%	-0.74%	4.28%	-3.16%	0.29%	1.57%	3.10%
R&D	8.79M	9.46M	11.36M	13.23M	13.67M	16.17M	20.05M	23.52M	25.91M	43.10M	31.44M
R&D as % of Total Revenue	10.68%	10.23%	10.82%	10.90%	10.51%	12.67%	12.54%	12.86%	12.22%	19.17%	11.68%
Interest Expense	1.09M	961.72K	1.64M	1.58M	1.96M	1.37M	1.47M	4.62M	1.73M	6.80M	7.48M
Interest Expense % of Total Revenue	1.33%	1.04%	1.56%	1.30%	1.51%	1.07%	0.92%	2.53%	0.81%	3.03%	2.78%

Balance Sheet

Currency: CHF	2014-12-31	2015-12-31	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Total Assets	98.02M	103.02M	115.25M	130.49M	255.80M	288.51M	282.79M	298.18M	327.89M	349.53M	459.96M	559.92M
Total Liabilities	152.28M	149.97M	98.14M	113.45M	37.57M	72.94M	69.76M	74.18M	90.11M	94.58M	190.31M	284.05M
Total Equity	-54.26M	-46.95M	17.10M	17.04M	218.23M	215.57M	213.04M	224.00M	237.78M	254.96M	269.65M	275.87M
Cash	1.80M	1.35M	1.76M	1.97M	116.26M	99.57M	82.73M	82.64M	20.60M	25.20M	138.69M	32.97M
Total Debt	75.33M	79.73M	64.68M	74.57M	3.38M	26.43M	27.18M	24.07M	27.96M	27.39M	121.23M	157.72M
Net Debt	73.54M	78.38M	62.93M	72.60M	-112.88M	-73.14M	-55.56M	-58.57M	7.35M	2.19M	-18.39M	124.75M

Cash Flow

Currency: CHF	2015-12-31	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Operating Cash Flow	11.88M	11.91M	11.01M	6.45M	8.11M	12.61M	20.95M	-3.93M	19.98M	32.07M	34.82M
Investing Cash Flow	-9.49M	-8.62M	-16.63M	-14.38M	-19.36M	-22.86M	-15.87M	-52.91M	-37.83M	-19.06M	-146.26M
Financing Cash Flow	-2.80M	-2.85M	5.77M	122.81M	-4.71M	-4.73M	-4.78M	-3.90M	23.21M	100.58M	6.83M
Capital Expenditure	11.06M	8.53M	8.79M	14.48M	19.42M	13.07M	10.39M	18.79M	14.93M	7.17M	25.48M
Free Cash Flow	821.96K	3.38M	2.22M	-8.03M	-11.31M	-455.29K	10.57M	-22.72M	5.05M	21.00M	9.34M
FCF to OCF	6.92%	28.41%	20.19%	-124.56%	-139.39%	-3.61%	50.43%	578.53%	25.26%	65.48%	26.83%

Earnings

Report Date	Mar 22, 2018	Aug 22, 2018	Apr 2, 2019	Aug 20, 2019	Mar 3, 2020	Aug 18, 2020	Mar 10, 2021	Aug 17, 2021	Mar 7, 2022	Aug 16, 2022	Mar 14, 2023	Mar 18, 2025	Aug 19, 2025	Mar 17, 2026	Mar 16, 2027
EPS Estimate	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-	0.00	-	0.00	-	-	-
EPS Actual	-0.14	0.10	0.32	0.06	0.12	-0.50	0.41	0.60	-0.02	0.00	-0.49	0.08	-0.12	0.79	-
Surprise	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Timing	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	-	-	Pre-market	Pre-market	-	After-hours	After-hours	After-hours

Key Statistics & Ratios

Market Cap1.02B

Enterprise Value1.27B

Trailing P/E68.42

Forward P/E123.46

Price / Sales3.33

Price / Book3.85

EPS1.20

Book Value22.65

Revenue (TTM)307.05M

Gross Profit (TTM)237.89M

EBITDA29.08M

Profit Margin4.86%

Operating Margin8.93%

Return on Equity5.75%

Return on Assets1.03%

Shares Outstanding12.45M

Shares Float4.69M

Beta1.17

Dividend Yield0.00%

Dividend Rate0.00

Payout Ratio0.00%